Specific regulation of BACH1 by the hotspot mutant p53R175H reveals a distinct gain-of-function mechanism

被引:29
|
作者
Su, Zhenyi [1 ,2 ,3 ]
Kon, Ning [1 ,2 ,3 ]
Yi, Jingjie [1 ,2 ,3 ]
Zhao, Haiqing [4 ,5 ,6 ]
Zhang, Wanwei [7 ]
Tang, Qiaosi [3 ]
Li, Huan [1 ,2 ,3 ]
Kobayashi, Hiroki [8 ]
Li, Zhiming [1 ,2 ,3 ]
Duan, Shoufu [1 ,2 ,3 ]
Liu, Yanqing [1 ,2 ,3 ]
Olive, Kenneth P. P. [3 ,8 ]
Zhang, Zhiguo [1 ,2 ,3 ]
Honig, Barry [4 ,5 ,6 ]
Manfredi, James J. J. [9 ]
Rustgi, Anil K. K. [3 ]
Gu, Wei [1 ,2 ,3 ]
机构
[1] Columbia Univ, Inst Canc Genet, Vagelos Coll Phys & Surg, New York, NY 10027 USA
[2] Columbia Univ, Vagelos Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA
[3] Columbia Univ, Vagelos Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA
[4] Columbia Univ, Zuckerman Inst, Dept Biochem & Mol Biophys, New York, NY USA
[5] Columbia Univ, Zuckerman Inst, Dept Syst Biol, New York, NY USA
[6] Columbia Univ, Zuckerman Inst, Dept Med Sci Med, New York, NY USA
[7] Columbia Univ, Vagelos Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY USA
[8] Columbia Univ, Irving Med Ctr, Dept Med, Div Digest & Liver Dis, New York, NY USA
[9] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY USA
基金
美国国家卫生研究院;
关键词
PANCREATIC-CANCER METASTASIS; MASTER REGULATOR; MOUSE MODELS; P53; TRANSCRIPTION; GENE; DEMETHYLASE; FERROPTOSIS; ACTIVATION; MUTATION;
D O I
10.1038/s43018-023-00532-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Su et al. find that BACH1 specifically interacts with the p53 (R175H) hotspot mutant. This has double oncogenic effects, leading to increased expression of the pro-metastatic targets of BACH1 as well as blockage of its capacity to activate ferroptosis. Although the gain of function (GOF) of p53 mutants is well recognized, it remains unclear whether different p53 mutants share the same cofactors to induce GOFs. In a proteomic screen, we identified BACH1 as a cellular factor that recognizes the p53 DNA-binding domain depending on its mutation status. BACH1 strongly interacts with p53(R175H) but fails to effectively bind wild-type p53 or other hotspot mutants in vivo for functional regulation. Notably, p53(R175H) acts as a repressor for ferroptosis by abrogating BACH1-mediated downregulation of SLC7A11 to enhance tumor growth; conversely, p53(R175H) promotes BACH1-dependent tumor metastasis by upregulating expression of pro-metastatic targets. Mechanistically, p53(R175H)-mediated bidirectional regulation of BACH1 function is dependent on its ability to recruit the histone demethylase LSD2 to target promoters and differentially modulate transcription. These data demonstrate that BACH1 acts as a unique partner for p53(R175H) in executing its specific GOFs and suggest that different p53 mutants induce their GOFs through distinct mechanisms.
引用
收藏
页码:564 / +
页数:41
相关论文
共 50 条
  • [21] Gain-of-function mutant p53-R280K mediates survival of breast cancer cells
    Bae, Yun-Hee
    Shin, Jong-Myung
    Park, Hyun-Joo
    Jang, Hye-Ock
    Bae, Moon-Kyoung
    Bae, Soo-Kyung
    GENES & GENOMICS, 2014, 36 (02) : 171 - 178
  • [22] Gain-of-function mutant p53-R280K mediates survival of breast cancer cells
    Yun-Hee Bae
    Jong-Myung Shin
    Hyun-Joo Park
    Hye-Ock Jang
    Moon-Kyoung Bae
    Soo-Kyung Bae
    Genes & Genomics, 2014, 36 : 171 - 178
  • [23] Selective degradation of the p53-R175H oncogenic hotspot mutant by an RNA aptamer-based PROTAC
    Kong, Lingping
    Meng, Fanlu
    Wu, Sijin
    Zhou, Ping
    Ge, Ruixin
    Liu, Min
    Zhang, Linlin
    Zhou, Jun
    Zhong, Diansheng
    Xie, Songbo
    CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (02):
  • [24] Cdkn2a suppresses metastasis in squamous cell carcinomas induced by the gain-of-function mutant p53R172H
    Li, Zhongyou
    Gonzalez, Cassandra L.
    Wang, Bingbing
    Zhang, Yuanyuan
    Mejia, Olga
    Katsonis, Panagiotis
    Lichtarge, Olivier
    Myers, Jeffrey N.
    El-Naggar, Adel K.
    Caulin, Carlos
    JOURNAL OF PATHOLOGY, 2016, 240 (02): : 224 - 234
  • [25] Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities
    Iyer, Swathi V.
    Parrales, Alejandro
    Begani, Priya
    Narkar, Akshay
    Adhikari, Amit S.
    Martinez, Luis A.
    Iwakuma, Tomoo
    ONCOTARGET, 2016, 7 (05) : 5401 - 5415
  • [26] The p53R172H gain-of-function mutation promotes resistance to oral cancer immunoprevention
    Wang, Jin
    Hu, Yuan
    Gonzalez, Cassandra
    Tang, Lin
    Wang, Bingbing
    El-Naggar, Adel
    Myers, Jeffrey
    Caulin, Carlos
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 36 - 37
  • [27] Proteasome inhibition paradoxically degrades gain-of-function mutant p53 R273H in NSCLC and could have therapeutic implications
    Oduah, Eziafa I.
    Sharfstein, Susan T.
    Seetharamu, Nagashree
    Grossman, Steven R.
    Litovchick, Larisa
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [28] Mutant p53 in head and neck squamous cell carcinoma: Molecular mechanism of gain-of-function and targeting therapy (Review)
    Li, Minmin
    Sun, Dongyuan
    Song, Ning
    Chen, Xi
    Zhang, Xinyue
    Zheng, Wentian
    Yu, Yang
    Han, Chengbing
    ONCOLOGY REPORTS, 2023, 50 (03)
  • [29] The C-terminus of Gain-of-Function Mutant p53 R273H Is Required for Association with PARP1 and Poly-ADP-Ribose
    Lundine, Devon
    Annor, George K.
    Chavez, Valery
    Maimos, Styliana
    Syed, Zafar
    Jiang, Shuhong
    Ellison, Viola
    Bargonetti, Jill
    MOLECULAR CANCER RESEARCH, 2022, 20 (12) : 1799 - 1810
  • [30] Gain-of-function hot spot mutant p53R248Q regulation of integrin/FAK/ERK signaling in esophageal squamous cell carcinoma
    Yu, Valen Zhuoyou
    So, Shan Shan
    Lung, Maria Li
    TRANSLATIONAL ONCOLOGY, 2021, 14 (01):